Literature DB >> 35422901

Diagnostic value of fibrinogen combined with thromboelastogram in postpartum hemorrhage after vaginal delivery.

Xiaojuan Zhu1, Jie Tang2, Xiaohong Huang2, Ying Zhou2.   

Abstract

OBJECTIVE: To investigate the diagnostic value of fibrinogen (Fib) combined with thromboelastogram (TEG) in postpartum hemorrhage (PPH) after vaginal delivery.
METHODS: A total of 120 women who underwent vaginal delivery in our hospital were divided into a PPH group (n=50) and a non-PPH group (n=70). The reaction time (R), clotting time (K), Fib, and D-dimer (D-D) levels were compared between the two groups. Patients in the PPH group were sub-divided into a mild hemorrhage group (n=28) and a severe hemorrhage group (n=22). The receiver operator characteristic curves of R, K, Fib, and D-D for predicting PPH were plotted respectively.
RESULTS: The levels of R, K, and D-D in the PPH group were significantly higher than those in the non-PPH group. The Fib level was significantly lower than that in the non-PPH group (P<0.05). The severe hemorrhage group had significantly higher maternal R, K, and D-D levels and a significantly lower Fib level than the mild hemorrhage group (P<0.05). Correlation analysis showed that Fib was negatively correlated with R and K, and the D-D was positively correlated with R and K (P<0.05). The area under the curves of R, K, Fib, and D-D were 0.9690, 0.9917, 0.8512, and 0.8771, respectively (P<0.05).
CONCLUSION: Fib and TEG have good diagnostic values for PPH in women who underwent vaginal delivery, and can better predict PPH, providing evidence for clinical prevention and treatment of PPH. AJTR
Copyright © 2022.

Entities:  

Keywords:  Fibrinogen; postpartum hemorrhage; thromboelastogram; vaginal delivery

Year:  2022        PMID: 35422901      PMCID: PMC8991141     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  26 in total

1.  Quantitative Blood Loss in Obstetric Hemorrhage: ACOG COMMITTEE OPINION, Number 794.

Authors: 
Journal:  Obstet Gynecol       Date:  2019-12       Impact factor: 7.661

2.  Postpartum Hemorrhage: Prevention and Treatment.

Authors:  Ann Evensen; Janice M Anderson; Patricia Fontaine
Journal:  Am Fam Physician       Date:  2017-04-01       Impact factor: 3.292

Review 3.  Postpartum hemorrhage: early identification challenges.

Authors:  Maria Andrikopoulou; Mary E D'Alton
Journal:  Semin Perinatol       Date:  2018-11-14       Impact factor: 3.300

Review 4.  Next Generation Medical Management of Postpartum Hemorrhage.

Authors:  Jaclyn M Phillips; John N van den Anker; Homa K Ahmadzia
Journal:  Curr Pharm Des       Date:  2019       Impact factor: 3.116

Review 5.  Postpartum Hemorrhage: Management of Massive Transfusion.

Authors:  Daneil L Jackson; Thomas G DeLoughery
Journal:  Obstet Gynecol Surv       Date:  2018-07       Impact factor: 2.347

6.  Postpartum hemorrhage: new insights for definition and diagnosis.

Authors:  A Borovac-Pinheiro; R C Pacagnella; J G Cecatti; S Miller; A M El Ayadi; J P Souza; J Durocher; P D Blumenthal; B Winikoff
Journal:  Am J Obstet Gynecol       Date:  2018-04-14       Impact factor: 8.661

Review 7.  Postpartum haemorrhage: prevention and treatment.

Authors:  Loïc Sentilhes; Benjamin Merlot; Hugo Madar; François Sztark; Stéphanie Brun; Catherine Deneux-Tharaux
Journal:  Expert Rev Hematol       Date:  2016-10-20       Impact factor: 2.929

Review 8.  Postpartum Hemorrhage.

Authors:  Janice Newsome; Jonathan G Martin; Zachary Bercu; Jay Shah; Haris Shekhani; Gail Peters
Journal:  Tech Vasc Interv Radiol       Date:  2017-10-10

Review 9.  Obstetric hemorrhage: A global review.

Authors:  Dena Goffman; Lisa Nathan; Cynthia Chazotte
Journal:  Semin Perinatol       Date:  2015-12-29       Impact factor: 3.300

10.  How well do postpartum blood loss and common definitions of postpartum hemorrhage correlate with postpartum anemia and fall in hemoglobin?

Authors:  Holly Anger; Jill Durocher; Rasha Dabash; Beverly Winikoff
Journal:  PLoS One       Date:  2019-08-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.